Quick answer
Acetyl tetrapeptide-5 can be considered for premium under-eye cosmetic concepts, but its use must be evaluated in the complete microneedle matrix and finished product.
Why brands consider it
Acetyl tetrapeptide-5 is used in cosmetic eye-care concepts associated with tired-looking or puffy under-eye appearance. For a microneedle patch, the relevant question is not whether the ingredient has a marketing dossier; it is whether the proposed finished formula is compatible, stable, safe and supportable.
Translate the concept into design inputs
Document target market, customer, permitted cosmetic claim direction, intended frequency, active level, supporting ingredients, matrix, patch contour, array area, backing and package. Mark which items are assumptions and which are confirmed.
Control development variables
Change one major variable at a time where practical. If formula, geometry and drying all change in one round, a successful or failed sample may not reveal the cause. Use written sample codes and acceptance criteria for appearance, handling, integrity and other relevant observations.
Substantiate the finished product
Ingredient literature can inform the rationale but does not automatically support the brand claim. Finished-product safety, stability and claim evidence must match the actual formula, pack, directions and market.
Commercial briefing points
- Target retail price and pack count
- Preferred claim language and market
- Standard or custom formula route
- Required sample quantity and timing
- Expected first order and forecast